Macrophage inflammatory protein-related protein-2, a novel CC chemokine, can regulate preadipocyte migration and adipocyte differentiation

FEBS Letters

Volumn 548, Issue 1-3, 2003, Pages 125-130

  Kim, Chu Sook ^a   Kawada, Teruo ^b   Yoo, Hoon ^c   Kwon, Byung Se ^a   Yu, Rina ^a  

^a University of Ulsan   (South Korea)

^b KYOTO UNIVERSITY   (Japan)

^c Chosun University   (South Korea)

Author keywords

Adipocyte; Adipogenesis; CC chemokine; Chemotaxis; Inflammation; Macrophage inflammatory protein related protein 2; Obesity; Preadipocytes

Indexed keywords

BETA CHEMOKINE; FATTY ACID BINDING PROTEIN; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; MACROPHAGE INFLAMMATORY PROTEIN RELATED PROTEIN 2; UNCLASSIFIED DRUG; CCL9 PROTEIN, MOUSE; MACROPHAGE INFLAMMATORY PROTEIN; MESSENGER RNA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; FEMALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CYTOLOGY; GENETICS; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; UPREGULATION;

ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CHEMOKINES, CC; CHEMOTAXIS; FEMALE; MACROPHAGE INFLAMMATORY PROTEINS; MICE; MICE, INBRED BALB C; OBESITY; RNA, MESSENGER; UP-REGULATION;

EID: 0041736052     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(03)00728-2     Document Type: Article

References (22)

1. Wasserman, F. (1965) in: Handbook of Physiology, 87-100, American Physiological Society, Washinton, DC.
2. Crandall D.L., Quinet E.M., Morgan G.A., Busler D.E., McHendry-Rinde B., Kral J.G. J. Clin. Endocrinol. Metab. 84:1999;3222-3227.
3. Coppack S.W. Proc. Nutr. Soc. 60:2001;349-356.
4. Shimomura I., Funahashi T., Takahashi M., Maeda K., Kotani K., Nakamura T., Yamashita S., Miura M., Fukuda Y., Takemura K., Tokunaga K., Matsuzawa Y. Nat. Med. 2:1996;800-803.
5. Hotamisligil G.S., Murray D.L., Choy L.N., Spiegelman B.M. Proc. Natl. Acad. Sci. USA. 91:1994;4854-4858.
6. Crandall D.L., Busler D.E., McHendry-Rinde B., Groeling T.M., Kral J.G. J. Clin. Endocrinol. Metab. J. 85:2000;2609-2614.
7. Roytblat L., Rachinsky M., Fisher A., Greemberg L., Shapira Y., Douvdevani A., Gelman S. Obes. Res. 8:2000;673-675.
8. Chu N.F., Spiegelman D., Hotamisligil G.S., Rifai N., Stampfer M., Rimm E.B. Atherosclerosis. 157:2001;495-503.
9. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., Harris T.B. Jama. 282:1999;2131-2135.
10. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G. Am. J. Physiol. Endocrinol. Metab. 280:2001;E745-51.
11. Baggiolini M. Nature. 392:1998;565-568.
12. Gerhardt C.C., Romero I.A., Cancello R., Camoin L., Strosberg A.D. Mol. Cell Endocrinol. 175:2001;81-92.
13. Youn B.S., Jang I.K., Broxmeyer H.E., Cooper S., Jenkins N.A., Gilbert D.J., Copeland N.G., Elick T.A., Fraser M.J. Jr., Kwon B.S. J. Immunol. 155:1995;2661-2667.
14. Lee W.H., Kim S.H., Jeong E.M., Choi Y.H., Kim D.I., Lee B.B., Cho Y.S., Kwon B.S., Park J.E. Atherosclerosis. 161:2002;255-260.
15. Yu R., Park J.S., Kawada T., Kwon B.S. Life Sci. 70:2002;2535-2545.
16. Takahashi N., Kawada T., Goto T., Yamamoto T., Taimatsu A., Matsui N., Kimura K., Saito M., Hosokawa M., Miyashita K., Fushiki T. FEBS Lett. 514:2002;315-322.
17. Poltorak A.N., Bazzoni F., Smirnova I.I., Alejos E., Thompson P., Luheshi G., Rothwell N., Beutler B. J. Inflamm. 45:1995;207-219.
18. Kletzien R.F., Foellmi L.A., Harris P.K., Wyse B.M., Clarke S.D. Mol. Pharmacol. 42:1992;558-562.
19. Ogawa Y., Masuzaki H., Isse N., Okazaki T., Mori K., Shigemoto M., Satoh N., Tamura N., Hosoda K., Yoshimasa Y. J. Clin. Invest. 96:1995;1647-1652.
20. Masuzaki H., Ogawa Y., Hosoda K., Kawada T., Fushiki T., Nakao K. Biochem. Biophys. Res. Comm. 216:1995;355-358.
21. Greenberg A.S., McDaniel M.L. Eur. J. Clin. Invest. 32:2002;24-34.
22. Cousin B., Munoz O., Andre M., Fontanilles A.M., Dani C., Cousin J.L., Laharrague P., Casteilla L., Penicaud L. Faseb J. 13:1999;305-312.